This company is no longer active
LSPR Stock Overview
Larkspur Health Acquisition Corp. does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Larkspur Health Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.50 |
| 52 Week High | US$25.00 |
| 52 Week Low | US$7.21 |
| Beta | 0 |
| 11 Month Change | -25.67% |
| 3 Month Change | -24.62% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -23.86% |
Recent News & Updates
Shareholder Returns
| LSPR | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -23.4% | 2.1% | 2.2% |
| 1Y | n/a | 55.8% | 32.6% |
Return vs Industry: Insufficient data to determine how LSPR performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how LSPR performed against the US Market.
Price Volatility
| LSPR volatility | |
|---|---|
| LSPR Average Weekly Movement | 52.5% |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LSPR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine LSPR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Dan O'Connor | lsprhealth.com |
Larkspur Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the biotechnology sector in the United States.
Larkspur Health Acquisition Corp. Fundamentals Summary
| LSPR fundamental statistics | |
|---|---|
| Market cap | US$75.22m |
| Earnings (TTM) | -US$2.11m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-35.6x
P/E RatioIs LSPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSPR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.11m |
| Earnings | -US$2.11m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did LSPR perform over the long term?
See historical performance and comparison